about
Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cellsExosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial SepsisOverexpression of miR-223 Tips the Balance of Pro- and Anti-hypertrophic Signaling Cascades toward Physiologic Cardiac Hypertrophy.Loss of duplexmiR-223 (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis.MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.Versatile effects of bacterium-released membrane vesicles on mammalian cells and infectious/inflammatory diseases.MicroRNA-223-5p and -3p Cooperatively Suppress Necroptosis in Ischemic/Reperfused Hearts.Hsp20-Mediated Activation of Exosome Biogenesis in Cardiomyocytes Improves Cardiac Function and Angiogenesis in Diabetic Mice.Circulating Exosomes Isolated from Septic Mice Induce Cardiovascular Hyperpermeability Through Promoting Podosome Cluster Formation.Regulation of BECN1-Mediated Autophagy by HSPB6: Insights from A Human HSPB6(S10F) Mutant.Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy.Hypoxic exosomes promote angiogenesis.Tsg101 positively regulates physiologic-like cardiac hypertrophy through FIP3-mediated endosomal recycling of IGF-1RAn Hsp20-FBXO4 Axis Regulates Adipocyte Function through Modulating PPARγ UbiquitinationCardioprotection via the skin: nociceptor-induced conditioning against cardiac MI in the NIC of timeTumor susceptibility gene 101 ameliorates endotoxin-induced cardiac dysfunction by enhancing Parkin-mediated mitophagyMicroRNA-223 is essential for maintaining functional β-cell mass during diabetes through inhibiting both FOXO1 and SOX6 pathwaysGDF3 Protects Mice against Sepsis-Induced Cardiac Dysfunction and Mortality by Suppression of Macrophage Pro-Inflammatory Phenotype
P50
Q33995548-27A09E56-B086-42D0-B32A-09C1FA6A54F0Q36035220-F0FEE81F-D9A0-4D7B-94DA-C8AEA2A62142Q37117314-134293F9-9C81-4FB0-847E-A74182F6DA33Q37647960-76BFCC3A-320B-4006-9E76-E6145727FA11Q38765627-A712EBD1-1F92-433D-9731-FD145CD1E6E0Q40072834-9BA5AA10-9C0B-49E7-ACBA-432E028D5F55Q41107035-1592F111-224D-456C-9C2C-597E8DB778DAQ41640134-8549981F-B160-44C0-974E-0AB317520B51Q46344453-3D8389E9-3F4F-4197-B954-576D68952CA7Q47382997-7AAAB2BA-A22E-4BCC-9A6B-CB61646AC13BQ47763435-4B50A1A1-3D97-4F32-8479-C8FE630593CAQ48246166-BB9D8955-865A-4719-B83C-F06FF8BE6A46Q64374842-1AAF5137-D2FF-44BE-A5F9-875FAC825EB0Q89167890-6937A505-F1C7-4D5F-9791-AE1A9E4EA0DEQ90692349-D4B94F65-4934-4442-A4F7-D9495110490CQ90753419-5972EEB5-985D-417B-A5BF-B2F43D6F48F6Q92225839-31246443-4F39-4A48-BBBB-BF283320E413Q92704148-2530309A-1208-4FB6-A1C5-4B182C8FAC53
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Guo-Chang Fan
@en
Guo-Chang Fan
@nl
type
label
Guo-Chang Fan
@en
Guo-Chang Fan
@nl
prefLabel
Guo-Chang Fan
@en
Guo-Chang Fan
@nl
P108
P31
P496
0000-0002-0439-8277